Amgen and Kite Pharma in cancer immunotherapy pact By: MarketWatch January 05, 2015 at 10:00 AM EST Agreement to focus on Amgen’s cancer targets and Kite’s autologous cell therapy platform. Read More >> Related Stocks: Amgen